PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31895025-1	2019	OBJECTIVE: The aim of this study was to observe the impacts of the specific cyclooxygenase-2 inhibitor celecoxib on cardiac structures, functions, and inflammatory factors during the process of pressure overload-induced myocardial hypertrophy.	celecoxib	103-112	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	76-92	
31628940-2	2020	The current study aimed to explore the potential protective impacts of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, on gentamicin-induced nephrotoxicity and the potential mechanisms in rats.	celecoxib	71-80	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	94-110	
31628940-2	2020	The current study aimed to explore the potential protective impacts of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, on gentamicin-induced nephrotoxicity and the potential mechanisms in rats.	celecoxib	71-80	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	112-117	
31628940-7	2020	In immunohistochemistry, celecoxib-treated rats showed decreased immunoreactivity against COX-2 in tubular cells and a mild positive immunoreactivity against heat shock protein 70 (HSP70) in renal interstitial cells.	celecoxib	25-34	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	90-95	
31693705-2	2019	Using the selective inhibitors celecoxib and zaltoprofen, cyclooxygenase-2 has been shown to be involved in the initiation, but not the maintenance, of muscular mechanical hyperalgesia induced by lengthening contractions, which serves as a useful model for the study of myofascial pain syndrome.	celecoxib	31-40	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	58-74